IRIS PubliCatt

Marrocco, Ilaria
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 92
NA - Nord America 59
AS - Asia 28
Totale 179
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 57
IE - Irlanda 37
IT - Italia 27
IN - India 22
SE - Svezia 13
DE - Germania 8
CZ - Repubblica Ceca 3
CA - Canada 2
CN - Cina 2
GB - Regno Unito 2
TW - Taiwan 2
AT - Austria 1
FI - Finlandia 1
PK - Pakistan 1
SG - Singapore 1
Totale 179
Salva come PNG Salva come JPEG
Città #
Ashburn 48
Dublin 37
Pune 21
Milan 10
Rome 8
New York 6
Halle 4
Brno 3
Beijing 2
Brescia 2
Edmonton 2
Erba 2
Frankfurt am Main 2
Nuremberg 2
Tainan City 2
Vercelli 2
Chiswick 1
Lappeenranta 1
London 1
San Antonio 1
Seattle 1
Singapore 1
Vienna 1
Totale 160
Salva come PNG Salva come JPEG
Nome #
Punicalagin, an active pomegranate component, is a new inhibitor of PDIA3 reductase activity 14
A combination of approved antibodies overcomes resistance of lung cancer to osimertinib by blocking bypass pathways 14
L858R emerges as a potential biomarker predicting response of lung cancer models to anti-EGFR antibodies: Comparison of osimertinib vs. cetuximab 14
ERp57 chaperon protein protects neuronal cells from Aβ-induced toxicity 14
Increased intake of energy-dense diet and negative energy balance in a mouse model of chronic psychosocial defeat 10
Host-dependent phenotypic resistance to EGFR tyrosine kinase inhibitors 10
Measurement and Clinical Significance of Biomarkers of Oxidative Stress in Humans 9
Egfr in cancer: Signaling mechanisms, drugs and acquired resistance 9
Inhibition of a pancreatic cancer model by cooperative pairs of clinically approved and experimental antibodies 9
Clustering of IRE1α depends on sensing ER stress but not on its RNase activity 9
An interdomain helix in IRE1α mediates the conformational change required for the sensor's activation 8
Targeting her3, a catalytically defective receptor tyrosine kinase, prevents resistance of lung cancer to a third-generation egfr kinase inhibitor 8
Roles for growth factors and mutations in metastatic dissemination 8
Upfront admixing antibodies and EGFR inhibitors preempts sequential treatments in lung cancer models 8
Roles for receptor tyrosine kinases in tumor progression and implications for cancer treatment 8
Shmt2: A Stat3 signaling new player in prostate cancer energy metabolism 8
Cancer Immunotherapy: The Dawn of Antibody Cocktails 8
An oligoclonal antibody durably overcomes resistance of lung cancer to third-generation EGFR inhibitors 7
ETS Proteins Bind with Glucocorticoid Receptors: Relevance for Treatment of Ewing Sarcoma 7
TSHZ2 is an EGF-regulated tumor suppressor that binds to the cytokinesis regulator PRC1 and inhibits metastasis 6
Comparative analysis of the interaction between different flavonoids and PDIA3 6
Analysis of STAT3 post-translational modifications (PTMs) in human prostate cancer with different Gleason Score 6
Resistance of Lung Cancer to EGFR-Specific Kinase Inhibitors: Activation of Bypass Pathways and Endogenous Mutators 2
Totale 202
Salva come PNG Salva come JPEG
Categoria #
all - tutte 2.595
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.595
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/202345 0 0 0 0 0 0 0 0 25 16 4 0
2023/2024157 2 44 0 34 10 43 11 3 1 9 0 0
Totale 202